Coeptis Therapeutics

About:

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Website: https://coeptistx.com

Twitter/X: coeptistx

Top Investors: CJC

Description:

Coeptis Therapeutics is a clinical stage biotechnology company developing innovative cell therapy platforms for patients with cancer and other debilitating diseases. It focuses on the development and acquisition of pharmaceutical products. Its pipeline is evolving from the partnerships being created with multiple pharmaceutical companies. As the relationships unfold, the product pipeline will be updated accordingly.

Total Funding Amount:

$15.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wexford, Pennsylvania, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)coeptistx.com

Founders:

Christine Sheehy, Dan Yerace

Number of Employees:

11-50

Last Funding Date:

2024-06-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai